Chronic Kidney Disease (CKD) is a major global public health concern affecting approximately 10% of the world's population and contributing significantly to morbidity, mortality, and healthcare expenditures. CKD is characterized by progressive loss of kidney function, leading to complications such as cardiovascular disease, anemia, mineral bone disorders, electrolyte imbalances, and end-stage kidney disease (ESKD). Recent advances in nephrology have transformed CKD management through earlier diagnosis, novel pharmacological therapies, precision medicine approaches, artificial intelligence-assisted diagnostics, remote monitoring systems, and innovative renal replacement therapies. This review examines contemporary advances in CKD management, highlighting emerging therapeutic strategies, technological innovations, and future directions. Findings suggest that sodium-glucose co-transporter-2 (SGLT2) inhibitors, non-steroidal mineralocorticoid receptor antagonists, personalized medicine, and digital health interventions have significantly improved patient outcomes. Despite these advancements, challenges remain regarding healthcare access, treatment adherence, cost-effectiveness, and disease awareness. The study concludes that multidisciplinary and patient-centered approaches are essential for optimizing CKD outcomes and reducing the global burden of kidney disease.